Australia markets closed

Baxter International Inc. (BAX)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
78.51+0.37 (+0.47%)
At close: 4:00PM EST
Full screen
Trade prices are not sourced from all markets
Previous close78.14
Open78.25
Bid77.31 x 1000
Ask0.00 x 900
Day's range77.48 - 78.67
52-week range69.10 - 95.19
Volume2,503,715
Avg. volume2,869,118
Market cap39.656B
Beta (5Y monthly)0.66
PE ratio (TTM)36.86
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yield0.98 (1.25%)
Ex-dividend date25 Feb 2021
1y target estN/A
All
News
Press releases
  • Baxter Appoints Dr. David Wilkes to Its Board and Albert Stroucken as Lead Independent Director
    Business Wire

    Baxter Appoints Dr. David Wilkes to Its Board and Albert Stroucken as Lead Independent Director

    Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced it has appointed David S. Wilkes, M.D., dean, University of Virginia School of Medicine, and co-founder and chief scientific officer of biotech start-up ImmuneWorks Inc., to its board of directors. Dr. Wilkes will serve on Baxter’s Quality, Compliance and Technology Committee. Additionally, Baxter has appointed Albert P.L. Stroucken, former executive chairman and chief executive officer, Owens-Illinois, Inc., and a Baxter director since 2004, as its lead independent director. Mr. Stroucken, who previously served as the chairman of the Audit Committee, will succeed Thomas T. Stallkamp, who has served as lead independent director from May 2014 to February 2021. Mr. Stallkamp will continue to serve as a director of the board. Both new appointments are effective today and will bring the total number of directors serving the company to 13.

  • Baxter Declares Quarterly Dividend
    Business Wire

    Baxter Declares Quarterly Dividend

    Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced that its Board of Directors has declared a quarterly cash dividend of $0.245 per share of common stock. The dividend is payable on April 1, 2021, to shareholders of record as of February 26, 2021. The indicated annual dividend rate is $0.98 per share of common stock.

  • Baxter Reports Fourth-Quarter and Full-Year 2020 Results
    Business Wire

    Baxter Reports Fourth-Quarter and Full-Year 2020 Results

    Baxter International Inc. (NYSE:BAX), a leading global medical products company, today reported results for the fourth quarter and full year ended December 31, 2020, and provided its financial guidance for 2021.